FIELD: pharmacology.
SUBSTANCE: invention relates to compounds of the formula II
,
where R is H, OH, OCH3, or two R taken together form -OCH2O- or -OCF2O-; R1 is H or up to two C1-C6alkyls; R2 is H or halogen; and R3 is H or C1-C6 alkyl; R3 is H or C1-C6 alkyl; Y is O or NR4; and R4 is H or C1-C6 alkyl, and their pharmaceutical compositions useful as modulators of ATP-binding cassette ("ABC") transporters, or fragments thereof, including a cystic fibrosis transmembrane conduction regulator ("CFTR"). This invention also relates to methods for treatment of diseases mediated by ABC transporters using the compounds of the invention.
EFFECT: increased efficiency of treatment.
19 cl, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2008 |
|
RU2512682C2 |
| HETEROCYCLIC MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTER | 2006 |
|
RU2463303C2 |
| HETEROCYCLIC MODULATORS OF TRANSPORTERS OF AN ATP-BINDING CASSETTE | 2016 |
|
RU2765714C2 |
| HETEROCYCLIC MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2012 |
|
RU2608610C2 |
| METHODS AND INTERMEDIATE PRODUCTS | 2006 |
|
RU2446171C2 |
| METHOD OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS | 2011 |
|
RU2745977C2 |
| SOLID FORMS OF (R)-1-(2,2-DIFLUOROBENZO[d][1,3]DIOXOL-5-YL)-N-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL)CYCLOPROPANE CARBOXAMIDE | 2011 |
|
RU2573830C2 |
| METHOD FOR PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS | 2011 |
|
RU2569678C2 |
| METHOD OF OBTAINING MODULATORS OF CYSTIC FIBROUSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | 2010 |
|
RU2543714C2 |
| METHODS AND INTERMEDIATE COMPOUNDS | 2010 |
|
RU2531588C2 |
